Literature DB >> 2646162

The early management of hips in cerebral palsy.

D Scrutton1.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2646162     DOI： 10.1111/j.1469-8749.1989.tb08419.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN： 0012-1622            Impact factor:   5.449


× No keyword cloud information.
  8 in total

1.  Surveillance measures of the hips of children with bilateral cerebral palsy.

Authors:  D Scrutton; G Baird
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

2.  The role for hip surveillance in children with cerebral palsy.

Authors:  Benjamin Shore; David Spence; Hk Graham
Journal:  Curr Rev Musculoskelet Med       Date:  2012-06

Review 3.  Orthopaedic management of cerebral palsy.

Authors:  J A Fixsen
Journal:  Arch Dis Child       Date:  1994-11       Impact factor: 3.791

4.  Reliability of hip migration index in children with cerebral palsy: the classic and modified methods.

Authors:  Sun Mi Kim; Eun Geol Sim; Seong Gyu Lim; Eun Sook Park
Journal:  Ann Rehabil Med       Date:  2012-02-29

5.  [Long-term results of reconstructive surgery in infantile cerebral palsy patients with high hip dislocation: is hip screening necessary?].

Authors:  F Braatz; A Eidemüller; M C Klotz; S I Wolf; T Dreher
Journal:  Orthopade       Date:  2014-09       Impact factor: 1.087

6.  Surgical prevention of paralytic dislocation of the hip in cerebral palsy.

Authors:  G Cobeljić; Z Vukasinović; I Djorić
Journal:  Int Orthop       Date:  1994-10       Impact factor: 3.075

7.  Utility of combined hip abduction angle for hip surveillance in children with cerebral palsy.

Authors:  Akshay Divecha; Atul Bhaskar
Journal:  Indian J Orthop       Date:  2011-11       Impact factor: 1.251

8.  Hip dysplasia among children with spastic cerebral palsy in rural Bangladesh.

Authors:  Tasneem Karim; Mahmudul Hassan Al Imam; Prue Golland; Aynul Islam Khan; Iqbal Hossain; Hayley Smithers-Sheedy; Nadia Badawi; Mohammad Muhit; Gulam Khandaker
Journal:  BMC Musculoskelet Disord       Date:  2019-10-27       Impact factor: 2.362
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.